PedAM
Pediatric Disease Annotations & Medicines
| Disease | nephrogenic systemic fibrosis |
| Phenotype | C1561644|chronic kidney disease (ckd) |
| Sentences | 3 |
| PubMedID- 24582176 | nephrogenic systemic fibrosis (nsf) occurs in patients with advanced chronic kidney disease (ckd) or acute renal failure, most commonly following exposure to gadolinium-based contrast agents (gbcas). |
| PubMedID- 25890198 | One important limitation of contrast enhanced cmr using gadolinium chelates is the risk of nephrogenic systemic fibrosis in patients with advanced chronic kidney disease (ckd)(glomerular filtration rate < 30 ml/min/1.73 m2) [9], which commonly coexists with pad [10]. |
| PubMedID- 26295633 | Objective: the purpose of this study was to determine the incidence of nephrogenic systemic fibrosis (nsf) in patients with chronic kidney disease (ckd) and moderate-to-severe impairment of kidney function who had not previously been exposed to gadolinium-based contrast agents (gbcas) or referred to undergo contrast-enhanced mri with gadobenate dimeglumine or gadoteridol. |
Page: 1